Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Esteve

Showing results (131-140 of 223) with videos related to

Pageof 23
Sort By:
Antiviral Therapy|February 1, 2012
Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week studyJosep M Llibre, Maria J Buzón, Marta Massanella, et al.
Nature Medicine|March 16, 2010
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjectsMaria J Buzón, Marta Massanella, Josep M Llibre, et al.
Plant Physiology|August 14, 2024
Temporal and spatial frameworks supporting plant responses to vegetation proximityPedro Pastor-Andreu, Jordi Moreno-Romero, Mikel Urdin-Bravo, et al.
Nature Communications|May 29, 2021
Impact of DNA methylation on 3D genome structureDiana Buitrago, Mireia Labrador, Juan Pablo Arcon, et al.
Eye (London, England)|September 9, 2025
Personalised genomic strategies improve diagnostic yield in inherited retinal dystrophies: a stepwise, patient-centred approachAnna Esteve-Garcia, Ariadna Padró-Miquel, Jaume Català-Mora, et al.
Molecular Cancer Therapeutics|April 12, 2017
Genomic and Molecular Screenings Identify Different Mechanisms for Acquired Resistance to MET Inhibitors in Lung Cancer CellsPol Gimenez-Xavier, Eva Pros, Ester Bonastre, et al.
International Journal of Molecular Sciences|September 13, 2025
Transcriptomic Identification of Immune-Related Hubs as Candidate Predictor Biomarkers of Therapeutic Response in PsoriasisElisabet Cantó, María Elena Del Prado, Eva Vilarrasa, et al.
Neuromuscular Disorders : NMD|June 24, 2025
Multi-omics approach identifies a novel recessive pathogenic variant in the TNNT3 gene in two siblings with congenital myopathyJuliane S Müller, Shira Rabinowicz, Irina Zaharieva, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 23, 2024
Elderly patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors in a multicentre cohortHelena Pla, Eudald Felip, Verónica Obadia, et al.
World Journal of Urology|September 15, 2022
Nomogram based on baseline clinicopathological characteristics for predicting bladder cancer-specific survival to neoadjuvant chemotherapy in muscle-invasive bladder cancerAlbert Font, Montserrat Domenech, Oscar Buisan, et al.
Pageof 23

Showing results (131-140 of 223) with videos related to

Sort By:
Pageof 23
Antiviral Therapy|February 1, 2012
Treatment intensification with raltegravir in subjects with sustained HIV-1 viraemia suppression: a randomized 48-week studyJosep M Llibre, Maria J Buzón, Marta Massanella, et al.
Nature Medicine|March 16, 2010
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjectsMaria J Buzón, Marta Massanella, Josep M Llibre, et al.
Plant Physiology|August 14, 2024
Temporal and spatial frameworks supporting plant responses to vegetation proximityPedro Pastor-Andreu, Jordi Moreno-Romero, Mikel Urdin-Bravo, et al.
Nature Communications|May 29, 2021
Impact of DNA methylation on 3D genome structureDiana Buitrago, Mireia Labrador, Juan Pablo Arcon, et al.
Eye (London, England)|September 9, 2025
Personalised genomic strategies improve diagnostic yield in inherited retinal dystrophies: a stepwise, patient-centred approachAnna Esteve-Garcia, Ariadna Padró-Miquel, Jaume Català-Mora, et al.
Molecular Cancer Therapeutics|April 12, 2017
Genomic and Molecular Screenings Identify Different Mechanisms for Acquired Resistance to MET Inhibitors in Lung Cancer CellsPol Gimenez-Xavier, Eva Pros, Ester Bonastre, et al.
International Journal of Molecular Sciences|September 13, 2025
Transcriptomic Identification of Immune-Related Hubs as Candidate Predictor Biomarkers of Therapeutic Response in PsoriasisElisabet Cantó, María Elena Del Prado, Eva Vilarrasa, et al.
Neuromuscular Disorders : NMD|June 24, 2025
Multi-omics approach identifies a novel recessive pathogenic variant in the TNNT3 gene in two siblings with congenital myopathyJuliane S Müller, Shira Rabinowicz, Irina Zaharieva, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 23, 2024
Elderly patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors in a multicentre cohortHelena Pla, Eudald Felip, Verónica Obadia, et al.
World Journal of Urology|September 15, 2022
Nomogram based on baseline clinicopathological characteristics for predicting bladder cancer-specific survival to neoadjuvant chemotherapy in muscle-invasive bladder cancerAlbert Font, Montserrat Domenech, Oscar Buisan, et al.
Pageof 23